The $300m venture financing of Biofourmis was the medical devices industry’s top cross border venture financing deal as total deals worth $910m were announced globally in April 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 27.8% over the previous month of $712.04m and a drop of 26.02% when compared with the last 12-month average, which stood at $1.23bn.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $695.6m. At the country level, the US topped the list in terms of deal value at $665.6m.
In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of cross border venture financing deals activity in April 2022 was the US with nine deals, followed by the UK with four and Canada with three.
In 2022, as of April, medical devices cross border venture financing deals worth $3.77bn were announced globally, marking an increase of 12.4% year on year.
medical devices industry cross border venture financing deals in April 2022: Top deals
The top five medical devices industry cross border venture financing deals accounted for 74.2% of the overall value during April 2022.
The combined value of the top five medical devices cross border venture financing deals stood at $674.73m, against the overall value of $910m recorded for the month.
The top five medical devices industry cross border venture financing deals of April 2022 tracked by GlobalData were:
1) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis
2) The $150m venture financing of BostonGene by Impact Investment Partners,Japan Industrial Partners and NEC
3) Charles River Ventures,GV Management Co,Insight Partners,Kleiner Perkins,Scale Ventures,Sozo Ventures,Susa Ventures,Threshold Ventures and Tiger Global Management $100m venture financing deal with Viz.ai
4) The $70m venture financing of AI Medical Service by Globis Capital Partners &,Incubate Fund,SoftBank Vision Fund 2 and World Innovation Lab (WiL fund)
5) 3VC Partners,Balderton Capital,Eurazeo,heal.capital Management,Picus Capital and Vorwerk Ventures $54.73m venture financing deal with Avi Medical
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.